Microbiota dysbiosis and its pathophysiological significance in bowel obstruction

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Hegde, Shrilakshmi ^a   Lin, You Min ^a   Golovko, George ^a   Khanipov, Kamil ^a   Cong, Yingzi ^a   Savidge, Tor ^b   Fofanov, Yuriy ^a   Shi, Xuan Zheng ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; RNA 16S;

ANIMAL; BACTERIAL TRANSLOCATION; BACTERIUM IDENTIFICATION; BACTEROIDETES; CLASSIFICATION; COLON; DRUG EFFECT; DYSBIOSIS; FECES; FIRMICUTES; GENETICS; INTESTINE FLORA; INTESTINE OBSTRUCTION; ISOLATION AND PURIFICATION; LIVER; LYMPH NODE; MALE; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYLOGENY; PROTEOBACTERIA; RAT; SPLEEN; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TRANSLOCATION; BACTERIAL TYPING TECHNIQUES; BACTEROIDETES; COLON; DYSBIOSIS; FECES; FIRMICUTES; GASTROINTESTINAL MICROBIOME; INTESTINAL OBSTRUCTION; LIVER; LYMPH NODES; MALE; PHYLOGENY; PROTEOBACTERIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, RIBOSOMAL, 16S; SPLEEN;

EID: 85052750492     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-31033-0     Document Type: Article

References (71)

1. Shi, X. Z., Lin, Y. M., Powell, D. W. & Sarna, S. K. Pathophysiology of motility dysfunction in bowel obstruction: role of stretch-induced COX-2. Am J Physiol Gastrointest Liver Physiol 300, G99–G108, 10.1152/ajpgi.00379.2010 (2011)
2. Lin, Y. M., Li, F. & Shi, X. Z. Mechano-transcription of COX-2 is a common response to lumen dilation of the rat gastrointestinal tract. Neurogastroenterol Motil 24(670-677), e295–676, 10.1111/j.1365-2982.2012.01918.x (2012)
3. Summers, R. In Textbook of Gastroenterology Vol. 1 (eds Yamada, T. et al.) Ch. 39, 842–858 (Lippincott Williams and Wilkins, 1999)
4. Silen, W. In Harrison’s Principles of Internal Medicine Vol. 2 (eds Kasper, D. L. et al.) 1803–1805 (McGraw-Hill, 2005)
5. Russell, J. & Welch, J. In Bowel Obstruction (ed. Welch, J. P.) 28–58 (Saunders W.B., 1990)
6. De Giorgio, R., Cogliandro, R. F., Barbara, G., Corinaldesi, R. & Stanghellini, V. Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy. Gastroenterol Clin North Am 40, 787–807, 10.1016/j.gtc.2011.09.005 (2011)
7. Nunez, R., Blesa, E. & Cabrera, R. In Hirschsprung’s disease: Diagnosis and treatment (eds Nunez R. N. & Lopez-Alonso, M.) (Nova Science publishers, 2009)
8. Milenkovic, M., Russo, C. & Elixhauser, A. In Healthcare Cost and Utilization Project (HCUP) Statistical Briefs (Agency for Healthcare Research and Quality (US), 2006)
9. Stanković-Đorđević, D., Đorđević, N., Tasić, G., Dinić, M. & Bogdanović, M. Role of bacteria in Intestinal obstruction pathophysiological processes. Facta Universitatis 13, 127–132 (2006)
10. Lin, Y. M., Li, F. & Shi, X. Z. Mechanical stress is a pro-inflammatory stimulus in the gut: in vitro, in vivo and ex vivo evidence. PLoS One 9, e106242, 10.1371/journal.pone.0106242 (2014)
11. Zhu, B., Wang, X. & Li, L. Human gut microbiome: the second genome of human body. Protein Cell 1, 718–725, 10.1007/s13238-010-0093-z (2010)
12. Ramakrishna, B. S. Role of the gut microbiota in human nutrition and metabolism. J Gastroenterol Hepatol 28(Suppl 4), 9–17, 10.1111/jgh.12294 (2013)
13. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. & Kasper, D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107–118, 10.1016/j.cell.2005.05.007 (2005)
14. Rajilić-Stojanović, M. et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792–1801, 10.1053/j.gastro.2011.07.043 (2011)
15. Saulnier, D. M. et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141, 1782–1791, 10.1053/j.gastro.2011.06.072 (2011)
16. Malinen, E. et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100, 373–382, 10.1111/j.1572-0241.2005.40312.x (2005)
17. Distrutti, E., Monaldi, L., Ricci, P. & Fiorucci, S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol 22, 2219–2241, 10.3748/wjg.v22.i7.2219 (2016)
18. Kassinen, A. et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133, 24–33, 10.1053/j.gastro.2007.04.005 (2007)
19. Ahmed, I., Roy, B. C., Khan, S. A., Septer, S. & Umar, S. Microbiome, Metabolome and Inflammatory Bowel Disease. Microorganisms 4, https://doi.org/10.3390/microorganisms4020020 (2016)
20. Parkes, G. C. et al. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil 24, 31–39, 10.1111/j.1365-2982.2011.01803.x (2012)
21. Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M. & Owen, L. J. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 26, 26191 (2015)
22. Fielding, P. & Welch, J. Intestinal obstruction. 32–39 (Churchill Livingstone, 1987)
23. Jackson, P. G. & Raiji, M. T. Evaluation and management of intestinal obstruction. Am Fam Physician 83, 159–165 (2011)
24. Collins, S. M. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol 11, 497–505, 10.1038/nrgastro.2014.40 (2014)
25. Weinstock, G. M. Genomic approaches to studying the human microbiota. Nature 489, 250–256, 10.1038/nature11553 (2012)
26. Zoetendal, E. G., Rajilic-Stojanovic, M. & de Vos, W. M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605–1615, 10.1136/gut.2007.133603 (2008)
27. Kinross, J. M., Darzi, A. W. & Nicholson, J. K. Gut microbiome-host interactions in health and disease. Genome Med 3, 14, 10.1186/gm228 (2011)
28. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol 12, R60, 10.1186/gb-2011-12-6-r60 (2011)
29. Li, F., Lin, Y. M., Sarna, S. K. & Shi, X. Z. Cellular mechanism of mechanotranscription in colonic smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 303, G646–656, 10.1152/ajpgi.00440.2011 (2012)
30. 2 and EP receptors. Am J Physiol Gastrointest Liver Physiol 302, G267–275, 10.1152/ajpgi.00326.2011 (2012)
31. Ward, N. L., Pieretti, A., Dowd, S. E., Cox, S. B. & Goldstein, A. M. Intestinal aganglionosis is associated with early and sustained disruption of the colonic microbiome. Neurogastroenterol Motil 24, 874–e400, 10.1111/j.1365-2982.2012.01937.x (2012)
32. Pierre, J. F. et al. Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung’s disease. J Pediatr Surg 49, 1242–1251, 10.1016/j.jpedsurg.2014.01.060 (2014)
33. Benson, A. K. et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci USA 107, 18933–18938, 10.1073/pnas.1007028107 (2010)
34. Campbell, J. H. et al. Host genetic and environmental effects on mouse intestinal microbiota. ISME J 6, 2033–2044, 10.1038/ismej.2012.54 (2012)
35. Si, J. M., Yu, Y. C., Fan, Y. J. & Chen, S. J. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 10, 1802–1805 (2004)
36. Krogius-Kurikka, L. et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 9, 95, 10.1186/1471-230X-9-95 (2009)
37. Carroll, I. M., Ringel-Kulka, T., Siddle, J. P., Klaenhammer, T. R. & Ringel, Y. Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLoS One 7, e46953, 10.1371/journal.pone.0046953 (2012)
38. Carroll, I. M., Ringel-Kulka, T., Siddle, J. P. & Ringel, Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 24, 521–530, e248, https://doi.org/10.1111/j.1365-2982.2012.01891.x (2012)
39. Matsuoka, K. & Kanai, T. The gut microbiota and inflammatory bowel disease. Semin Immunopathol 37, 47–55, 10.1007/s00281-014-0454-4 (2015)
40. Willing, B. P. et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139, 1844–1854.e1841, 10.1053/j.gastro.2010.08.049 (2010)
41. Roediger, W. E. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 2, 712–715 (1980)
42. Vernia, P. et al. Fecal lactate and ulcerative colitis. Gastroenterology 95, 1564–1568 (1988)
43. Chassard, C. et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther 35, 828–838, 10.1111/j.1365-2036.2012.05007.x (2012)
44. Shi, X. Z., Winston, J. H. & Sarna, S. K. Differential immune and genetic responses in rat models of Crohn’s colitis and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 300, G41–51, 10.1152/ajpgi.00358.2010 (2011)
45. Shi, X. Z. Mechanical Regulation of Gene Expression in Gut Smooth Muscle Cells. Front Physiol 8, 1000, 10.3389/fphys.2017.01000 (2017)
46. Crouzet, L. et al. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil 25(4), e272–82, 10.1111/nmo.12103 (2013)
47. Becattini, S., Taur, Y. & Pamer, E. G. Antibiotic-induced changes in the intestinal microbiota and disease. Trends Mol Med 22(6), 458–478, 10.1016/j.molmed.2016.04.003 (2016)
48. Nagao-Kitamoto, H. et al. Functional characterization of inflammatory bowel disease-associated gut dysbiosis in gnotobiotic mice. Cell Mol Gastroenterol Hepatol. 3(2(4)), 468–481, 10.1016/j.jcmgh.2016.02.003 (2016)
49. Vandeputte, D. et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65, 57–62, 10.1136/gutjnl-2015-309618 (2016)
50. O’Boyle, C. J. et al. Microbiology of bacterial translocation in humans. Gut 42, 29–35 (1998)
51. Drouet, M. et al. Antibiotics induced commensal flora disruption favours escherichia coli AIEC colonization and mesenteric translocation in NOD2 knock-out mice. Journal of Translational Medicine 9, 8 (2011)
52. Griffin, A. J., Li, L. X., Voedisch, S., Pabst, O. & McSorley, S. J. Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse. Infect Immun 79, 1479–1488, 10.1128/IAI.01033-10 (2011)
53. Anitha, M., Vijay-Kumar, M., Sitaraman, S. V., Gewirtz, A. T. & Srinivasan, S. Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling. Gastroenterology 143, 1006–1016.e1004, 10.1053/j.gastro.2012.06.034 (2012)
54. Kashyap, P. C. et al. Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. Gastroenterology 144, 967–977, 10.1053/j.gastro.2013.01.047 (2013)
55. De Lisle, R. C., Roach, E. & Jansson, K. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 293, G577–584, 10.1152/ajpgi.00195.2007 (2007)
56. Anitha, M., Abraham, P. M. & Paulose, C. S. Striatal dopamine receptors modulate the expression of insulin receptor, IGF-1 and GLUT-3 in diabetic rats: effect of pyridoxine treatment. Eur J Pharmacol 696, 54–61, 10.1016/j.ejphar.2012.09.006 (2012)
57. Yang, M. et al. Involvement of gut microbiota in the association between GLP-1/GLP-1 receptor expression and gastrointestinal motility. Am J Physiol Gastrointest Liver Physiol, ajpgi.00232.02016, 10.1152/ajpgi.00232.2016 (2017)
58. Jernberg, C., Löfmark, S., Edlund, C. & Jansson, J. K. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156, 3216–3223, 10.1099/mic.0.040618-0 (2010)
59. Faber, F. et al. Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion. Nature 534, 697–699, 10.1038/nature18597 (2016)
60. Lopetuso, L. R., Scaldaferri, F., Petito, V. & Gasbarrini, A. Commensal Clostridia: leading players in the maintenance of gut homeostasis. Gut Pathog 5, 23, 10.1186/1757-4749-5-23 (2013)
61. Kamada, N., Chen, G. Y., Inohara, N. & Núñez, G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 14, 685–690, 10.1038/ni.2608 (2013)
62. Lin, Y. M. et al. Pathogenesis of abdominal pain in bowel obstruction: role of mechanical stress-induced upregulation of nerve growth factor in gut smooth muscle cells. Pain 158, 583–592, 10.1097/j.pain.0000000000000797 (2017)
63. Klindworth, A. et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res 41, e1, 10.1093/nar/gks808 (2013)
64. Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41, D590–596, 10.1093/nar/gks1219 (2013)
65. Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32, 1792–1797, 10.1093/nar/gkh340 (2004)
66. Magurran, A. E. Ecological Diversity and its Measurement. (Princeton University Press, 1988)
67. Rosenzweig, M. L. Species Diversity in Space and Time. (Cambridge University Press, 1995)
68. Begon, M., J. L. Harper, & C. R. Townsend. Ecology: Individuals, Populations, and Communities, 3rd edition. (Blackwell Science Ltd., 1996)
69. Wu, W. et al. Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. Mucosal Immunol, 10.1038/mi.2016.114 (2016)
70. Walker, A. W. et al. 16S rRNA gene-based profiling of the human infant gut microbiota is strongly influenced by sample processing and PCR primer choice. Microbiome 3, 26, 10.1186/s40168-015-0087-4 (2015)
71. Mao, S., Zhang, M., Liu, J. & Zhu, W. Characterising the bacterial microbiota across the gastrointestinal tracts of dairy cattle: membership and potential function. Sci Rep 5, 16116, 10.1038/srep16116 (2015)